Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE [Phase 3]

View source ↗

Summary

Phase 3 trial BLISS-BELIEVE evaluated belimumab in combination with rituximab for adults with systemic lupus erythematosus; the study completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)
• Rituxan (rituximab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: COMPLETED | Results posted: 2022-04-25